14-day Premium Trial Subscription Try For FreeTry Free

Where Allscripts Healthcare Stands With Analysts

04:03pm, Friday, 18'th Mar 2022 Benzinga
Allscripts Healthcare (NASDAQ:MDRX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 2 1 0 0

Masimo's (MASI) New Product Expansion to Boost Patient Outcome

02:00pm, Friday, 18'th Mar 2022 Zacks Investment Research
Masimo's (MASI) latest feature additions to its telehealth for Patient SafetyNet are likely to significantly improve patient outcomes.

Medtronic (MDT) Boosts Surgical Robotics Wing With New Deal

01:40pm, Friday, 18'th Mar 2022 Zacks Investment Research
According to Medtronic (MDT), Touch Surgery Enterprise is the first AI-powered platform of its kind for the operating room (OR). It is compatible with Medtronic's Hugo robotic-assisted surgery (RAS) s

Surging Earnings Estimates Signal Upside for AllScripts (MDRX) Stock

04:20pm, Thursday, 17'th Mar 2022 Zacks Investment Research
AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Reasons to Add AMN Healthcare (AMN) Stock to Your Portfolio

02:30pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Investors remain optimistic about AMN Healthcare (AMN) on its broad array of services.
AllScripts (MDRX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Here's Why You Should Retain Baxter (BAX) Stock For Now

03:39pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Baxter (BAX) due to its strong product portfolio.

Reasons to Retain Abiomed (ABMD) Stock in Your Portfolio For Now

04:55pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Investors remain optimistic about Abiomed (ABMD) due to strength in its Impella product line.

PerkinElmer's (PKI) Latest Launch to Boost Food Analysis Suite

04:31pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
PerkinElmer's (PKI) latest launch is likely to simplify the process of critical food analyses.

McKesson (MCK) Hits 52-Week High: What's Aiding the Stock?

03:26pm, Monday, 14'th Mar 2022 Zacks Investment Research
Investors are optimistic about McKesson's (MCK) strength in its Biologics business.

Baxter (BAX) to Enhance Its Portfolio With Latest Partnership

03:09pm, Monday, 14'th Mar 2022 Zacks Investment Research
Baxter's (BAX) latest strategic partnership with Digital Diagnostics is expected to expand its connected care diagnostics portfolio.

Here's Why You Should Retain Masimo (MASI) Stock For Now

04:50pm, Friday, 11'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient monitoring.
Allscripts Healthcare Solutions and Change Healthcare are included in this investment ideas blog.

Medical IT Providers Marching to Their Own Beat

05:30pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Medical IT Providers Marching to Their Own Beat

Reasons to Add Quidel (QDEL) Stock To Your Portfolio Now

03:51pm, Thursday, 10'th Mar 2022 Zacks Investment Research
Investors continue to be optimistic about Quidel (QDEL) owing to its strong diagnostics portfolio.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE